References

1 Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial co-ordination. Am J Respir Crit Care Med 1994;149:818-24.

2 Griffiths MJD, Evans TW. Adult respiratory distress syndrome. In: Brewis RAL, Corrin B, Geddes DM, Gibson GJ, eds. Respiratory medicine. 2nd ed. Philadelphia: WB Saunders, 1995: 605-29.

3 Luce JM. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 1998;26:369-76.

4 Deby-Dupont G, Lamy M. Pathophysiology of acute respiratory distress syndrome and acute lung injury. In: Webb A, Shapiro MJ, Singer M, Suter PM, eds. Oxford textbook of critical care. Oxford: Oxford University Press, 1999: 55-9.

5 Tomashefski JF Jr. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990;11:593-619.

6 Hudson LD, Milberg JA, Anardi D, et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301.

7 Marshall R, Bellingan G, Laurent G. The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax 1998;53:815-7.

8 Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomised controlled trial. JAMA 1999;282:54-61.

9 Milberg JA, Davis DR, Steinberg KP, et al. Improved survival of patients with acute respiratory distress syndrome (ARDS):1983-1993. JAMA 1995;273:306-9.

10 Abel SJ, Finney SJ, Brett SJ, et al. Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998;53:292-4.

11 Bion J. Pathophysiology of acute respiratory distress syndrome and acute lung injury. In: Webb A, Shapiro MJ, Singer M, Suter PM, eds. Oxford textbook of critical care. Oxford: Oxford University Press, 1999: 923-6.

12 Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) Consensus Conference Committee. Chest 1992;101:1644-55.

13 Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-8.

14 Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature Med 1997;3:678-81.

15 Desai SR, Wells AU, Suntharalingam G, et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary injury: a comparative CT study. Radiology 2001;218:689-93.

16 Hoelz C, Negri EM, Lichtenfels AJ, et al. Morphometric differences of pulmonary lesions in primary and secondary ARDS: a preliminary study in autopsies. Am J Respir Crit Care Med 2001;163:450.

17 Finney SJ, Robb JD, Suntharalinngam G, et al. ARDS due to direct and indirect pulmonary injuries: ICU survival, broncho-alveolar lavage neutrophil counts and oxygenation. Am J Respir Crit Care Med 2001;163:139.

18 Sadikot RT, Hao C, Jansen D, et al. Bioluminescent measurement of multiorgan Cox-2 gene expression in transgenic mice treated with LPS. Am J Respir Crit Care Med 2001;163:208.

19 Bachofen M, Wiebel ER. Structural alteration of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982;3:35-6.

20 Weiland JE, Davis WB, Holter JF, et al. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 1986;133:218-25.

21 Matsubara O, Tamura A, Ohdama S, et al. Alveolar basement membrane breaks down in diffuse alveolar damage: an immunohistochemical study. Pathol Int 1995;45:473-82.

22 Anderson WR, Thielen K. Correlative study of adult respiratory distress syndrome by light, scanning and transmission electron microscopy. Ultrastruct Pathol 1992;l16:615-28.

23 Snyder LS, Hertz MI, Peterson MS, et al. Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest 1991;88:663-73.

24 Marshall RP, Bellingan GJ, Laurent GJ. The fibroproliferative response to acute lung injury. In: Bellingan GJ, Laurent GJ, eds. Acute lung injury: from inflammation to repair. Amsterdam: IOS Press, 2000: 104-14.

25 Zapol WM, Trelstad R, Coffey JW, et al. Pulmonary fibrosis in severe acute respiratory failure. Am J Respir Crit Care Med 1979;119:547-54.

26 Raghu G, Striker LJ, Hudson LD, et al. Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis 1985;131:281-9.

27 McHugh LG, Milberg JA, Whitcomb ME, et al. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:90-4.

28 Suchyta MR, Elliott CG, Colby T, et al. Open lung biopsy does not correlate with pulmonary function after the adult respiratory distress syndrome. Chest 1991;99:1232-7.

29 Martin C, Papazian L, Payan MJ, et al. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995;107:196-200.

30 Chesnutt AN, Matthay MA, Tibayan FA, et al. Early detection of type III procollagen peptide in acute lung injury. Pathogenic and prognostic significance. Am J Respir Crit Care Med 1997; 156:840-5.

31 Marshall RP, Bellingan GJ, Gunn S, et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000;162:1783-8.

32 Montgomery AB, Stager MA, Carrico CJ, et al. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.

33 Bell RC, Coalson JJ, Smith JD, et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99:293-8.

34 Bellingan GJ, Marshall RP, Laurent GJ. Fibrosis in ARDS: how close is the link between inflammation and fibroproliferation? In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer, 2000: 217-24.

35 Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.

36 Rouby JJ, Lherm T, Martin de Lassale E, et al. Histologic aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure. Intensive Care Med 1993;19:383-9.

37 Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 1999;276:L688-94.

38 Kapanci Y, Wiebel ER, Kaplan HP, et al. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. 2. Ultrastructural and morphometric studies. Lab Invest 1969;20:101-8.

39 Bellingan G. Inflammatory cell activation in Sepsis. In: Evans TW, Bennett D Bion JF, et al, eds. Intensive care medicine. Br Med Bull 1999;55:12-29.

40 Bellingan GJ. Leukocyte: friend or foe? Intensive Care Med 2000;26:111-8.

41 Chollet-Martin S, Jourdain B, Gibert C, et al. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996;154:594-601.

42 Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 1998;11:1218-21.

43 Wax RS, Angus DC. The molecular genetics of sepsis. In: Vincent JL, ed. Yearbook ofintensive care and emergency medicine. Berlin: Springer, 2000: 3-17.

44 Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme I/D polymorphism in the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000;161:209.

45 Marshall RP, Webb S, Brull D, et al. Interleukin-6 (-174G>C) polymorphism predicts outcome in acute respiratory failure. Am J Respir Crit Care Med 2001;163:305.

46 Griffiths M. Transgenic and knockout mouse models of pulmonary inflammatory diseases. In: Bellingan GJ, Laurent GJ, eds. Acute lung injury: from inflammation to repair. Amsterdam: IOS Press, 2000: 93-104.

47 Meyrick B, Brigham KL. Acute effects of Eschericia coli endotoxin on the pulmonary microcirculation of anaesthetised sheep structure:function relationships. Lab Invest 1983;48:458-70.

48 Adler KB, Callahan LM, Evans JN. Cellular alterations in the alveolar wall in bleomycin-induced pulmonary fibrosis in rats. An ultrastructural morphometric study. Am Rev Respir Dis 1986;133:1043-8.

49 Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Esherichia coli endotoxin. J Clin Invest 1991;88:864-75.

50 Heflin AC, Brigham KL. Prevention by granulocyte depletion of increased lung vascular permeability of sheep following endotoxaemia. J Clin Invest 1981;68:1253-60.

51 Winn R, Maunder R, Chi E, et al. Neutrophil depletion does not prevent lung edema after endotoxin infusion in goats. J Appl Physiol 1987;62:116-21.

52 Braude S, Apperley J, Krausz T, et al. Adult respiratory distress syndrome after allogenic bone-marrow transplantation; evidence for a neutrophil-independent mechanism. Lancet 1985;i:1239-42.

53 Lee CT, Fein AM, Lippmann M, et al. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 1981;304:192-6.

54 Ward PA, Till GO, Kunkel R, et al. Evidence for the role of hydroxyl radical in complement and neutrophil dependent tissue injury. J Clin Invest 1983;72:789-801.

55 Zhang H, SlutskyAS, Vincent JL. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med 2000;26:474-6.

56 Armstrong L, Millar AB. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 1997;52:442-6.

57 Chua F, Dunsmore SE, Mutsaers SE, et al. Characterisation of the response to mice deficient in neutrophil elastase or cathepsin G to bleomycin. Am J Respir Crit Care Med 2001;163:231.

58 Donnelly SC, Haslett C, Dransfield I, et al. Role of selectins in development of adult respiratory distress syndrome. Lancet 1994;344:215-9.

59 Doershuk CM, Winn RK, Coxson HO, et al. CD18 dependent and independent mechanisms of neutrophil emigration in pulmonary and systemic microcirculation in rabbits. J Immunol 1990;144:2327-33.

60 Folkesson HG, Matthay MA. Inhibition of CD18 or CD11b attenuates acute lung injury after acid instillation in rabbits. J Appl Physiol 1997;82:1743-50.

61 Worthen GS, Schwab B III, Elson EL, et al. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 1989;245:183-6.

62 Pugin J, Ricou B, Steinberg KP, et al. Pro-inflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996;153:1850-6.

63 Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341:643-7.

64 Panacek EA. Results of the "MONARCS" phase III clinical trial of an anti-TNF-a antibody (afelimomab) in sepsis. Am J Respir Crit Care Med 2000;161:318.

65 Albertine KH. Histopathology of pulmonary oedema and the acute respiratory distress syndrome. In: Matthay MA, Ingbar DH, eds. Pulmonary edema. Lung Biology in Health and Disease. Volume 116. New York: Marcel Dekker, 1998: 37-84.

66 Hirani N, Clay, M, Sri-Pathmanathan, R, et al. A role for acute hypoxia/hyperoxia in the pathogenesis of the acute respiratory distress syndrome - an in vivo model. Thorax 1999;54(Suppl 3):A13.

67 Metnitz PG, Bartens C, Fischer M, et al. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999;25:180-5.

68 Haddad IY, Pataki G, Hu P, et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 1994;94:2407-13.

69 Matute-Bello G, Winn RK, Jonas M, et al. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol 2001;158:153-61

70 Matute-Bello G, Liles WC, Radella F, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;156:1969-77.

71 Robbins IM, Newman JH, Brigham KL. Increased-permeability pulmonary edema from sepsis/endotoxemia. In: Matthay MA, Ingbar DH, eds. Pulmonary edema. Lung Biology in Health and Disease. Volume 116. New York: Marcel Dekker, 1998: 203-46.

72 Griffiths MJ, Curzen NP, Mitchell JA, etal. In vivo treatment with endotoxin increases rat pulmonary vascular contractility despite NOS induction. Am J Respir Crit Care Med 1997;156:654-8.

73 Sibbald WJ, Paterson NA, Holliday RL, etal. Pulmonary hypertension in sepsis: measurement by the pulmonary artery diastolic wedge pressure gradient and the influence of passive and active factors. Chest 1978;73:583-91.

74 Druml W, Steltzer H, Waldhausl W, etal. Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1169-73.

75 Baudouin SV. Surfactant medication for acute respiratory distress syndrome. Thorax 1997;52:S9-15.

76 Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8:957-67.

77 Greene KE, Gardai S, Henson PM. SP-A and SP-D inhibit spontaneous neutrophil apoptosis via activation of the PI-3 kinase/AKT. Am J Respir Crit Care Med 2001;163:23.

78 Baker CS, Evans TW, Randle BJ, et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999;353:1232-7.

79 Miyazaki Y, Araki K, Vesin C, et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 1995;96:250-9.

80 Keane MP Belperio JA, Burdick MD, et al. IL-13 is an important cytokine in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2001;163:43.

81 Madtes DK, Rubenfeld G, Klima LD, etal. Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158 :424-30.

82 Henke C, Marineili W, Jessurun J, et al. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol 1993;143:1189-99.

83 Clark DA, Coker R. Transforming growth factor-beta (TGF-beta). IntJ Biochem Cell Biol 1998;30:293-8.

84 Khalil N, Greenberg AH. The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp 1991;157:194-207

85 Sime PJ, Xing Z, Graham FL, etal. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100:768-76.

86 Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-28.

87 Folkesson HG, MatthayMA, Hasegawa H, etal. Transcellular water transport in lung alveolar epithelium through mercury sensitive water channels Proc Natl Acad Sci USA 1994;91:4970-4.

89 Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar oedema in humans. Am Rev Respir Dis 1990;142:1250-7.

89 Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999;160:S5-11.

90 Ricou B, Nicod L, Lacraz S, et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:346-52.

91 Guyton AC, Lindsey AW. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary oedema. Circ Res 1959;VII:649-57.

Reducing Blood Pressure Naturally

Reducing Blood Pressure Naturally

Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.

Get My Free Ebook


Post a comment